Literature DB >> 6184153

Immunological heterogeneity of carcinoembryonic antigen: immunohistochemical detection of carcinoembryonic antigen determinants in colonic tumors with monoclonal antibodies.

F J Primus, W J Kuhns, D M Goldenberg.   

Abstract

The immunoperoxidase localization of carcinoembryonic antigen (CEA) determinants was studied in colonic adenocarcinomas using four murine monoclonal antibodies to CEA in a bridged avidin:biotin technique. One of the monoclonal antibodies, NP-1, recognizes a CEA epitope shared with the nonspecific cross-reacting antigen and meconium antigen. Two others, NP-2 and NP-3, discriminate two separate CEA epitopes shared with meconium antigen only, whereas NP-4 reacts with a unique determinant expressed on a subpopulation of CEA molecules. The monoclonal antibodies and polyclonal goat antisera against CEA and nonspecific cross-reacting antigen stained columnar epithelial cells in morphologically normal mucosa. Neutrophils were stained by only the NP-1 monoclonal antibody and goat anti-nonspecific cross-reacting antigen antiserum. All moderately differentiated colorectal adenocarcinomas and most of their nodal and liver metastases reacted with the goat antisera and cross-reactive monoclonal antibodies. Thirty % of these primary tumors and most of the nodal and/or liver metastases from six patients with NP-4-positive primary tumors failed to stain with NP-4. These results suggest heterogeneity in the expression of a CEA variant and/or determinant recognized by the NP-4 monoclonal antibody that perhaps identifies a subgroup of colonic cancers which differ in their functional differentiation.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6184153

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

Review 1.  Antibody-directed enzyme prodrug therapy.

Authors:  K D Bagshawe
Journal:  Clin Pharmacokinet       Date:  1994-11       Impact factor: 6.447

2.  Monoclonal antibodies against CEA-related components discriminate between pancreatic duct type carcinomas and nonneoplastic duct lesions as well as nonduct type neoplasias.

Authors:  B Bätge; K Bosslet; H H Sedlacek; H F Kern; G Klöppel
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

3.  Immunohistochemical study of colorectal adenocarcinomas and adenomas with antibodies against carcinoembryonic antigen (CEA), CA19-9, keratin, alpha-tubulin and secretory component (SC).

Authors:  T Taguchi; H Kijima; T Mitomi; R Y Osamura
Journal:  Gastroenterol Jpn       Date:  1991-06

4.  Human response against NP-4, a mouse antibody to carcinoembryonic antigen: human anti-idiotype antibodies mimic an epitope on the tumor antigen.

Authors:  M J Losman; H J Hansen; R M Sharkey; D M Goldenberg; M Monestier
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

5.  Variations in radioimmunoscintigraphic detection of tumor showed by five monoclonal antibodies to carcinoembryonic antigen.

Authors:  K Kohno; K Nakata; Y Kusumoto; N Ishii; T Kohji; Y Matsuoka; S Nishi; S Nagataki
Journal:  Ann Nucl Med       Date:  1991-07       Impact factor: 2.668

6.  Improved radioimmunotherapy of colorectal cancer xenografts using antibody mixtures against carcinoembryonic antigen and colon-specific antigen-p.

Authors:  R D Blumenthal; R Kashi; R Stephens; R M Sharkey; D M Goldenberg
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

7.  Epitopes of carcinoembryonic antigen (CEA) defined by monoclonal antibodies.

Authors:  M R Price
Journal:  Br J Cancer       Date:  1988-02       Impact factor: 7.640

Review 8.  The First Bagshawe lecture. Towards generating cytotoxic agents at cancer sites.

Authors:  K D Bagshawe
Journal:  Br J Cancer       Date:  1989-09       Impact factor: 7.640

9.  A cytotoxic agent can be generated selectively at cancer sites.

Authors:  K D Bagshawe; C J Springer; F Searle; P Antoniw; S K Sharma; R G Melton; R F Sherwood
Journal:  Br J Cancer       Date:  1988-12       Impact factor: 7.640

10.  Carcinoembryonic antigen (CEA) expression and heterogeneity in primary and autologous metastatic gastric tumours demonstrated by a monoclonal antibody.

Authors:  M S Hockey; H J Stokes; H Thompson; C S Woodhouse; F Macdonald; J W Fielding; C H Ford
Journal:  Br J Cancer       Date:  1984-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.